SKI Market

A+| A| A-|

Indian Indices

Sensex

73,583.22 -1,690.23
( -2.25%)

Global Indices

Nasdaq

45,986.51 -463.99
(-1.00%)

Dow Jones

6,496.71 -116.19
(-1.76%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,959.27 -12.90
(-0.13%)

Forex

USD-INR

93.86 0.07
(0.08%)

EUR-INR

108.76 0.06
(0.06%)

GBP-INR

125.66 0.01
(0.01%)

JPY-INR

0.59 0.00
(-0.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aptus Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

544529

INE15XJ01010

29.1342566

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

239.62

EPS(TTM)

Face Value()

Div & Yield %

Back

Tarmat consolidated net profit rises 256.10% in the September 2025 quarter

Nov 15,2025

Net profit of Tarmat rose 256.10% to Rs 1.46 crore in the quarter ended September 2025 as against Rs 0.41 crore during the previous quarter ended September 2024. Sales rose 45.60% to Rs 22.67 crore in the quarter ended September 2025 as against Rs 15.57 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	22.67	15.57	46
OPM %	4.98	3.53	-
PBDT	1.67	0.56	198
PBT	1.39	0.38	266
NP	1.46	0.41	256

73,583.22 -1,690.23 ( -2.25%)

45,986.51 -463.99 (-1.00%)

6,496.71 -116.19 (-1.76%)

53,412.46 -191.19 (-0.36%)

9,959.27 -12.90 (-0.13%)

93.86 0.07 (0.08%)

108.76 0.06 (0.06%)

125.66 0.01 (0.01%)

0.59 0.00 (-0.13%)